Latest / Wilmington News Today | 2 Min News | The Daily News Now!
Peptides in the Spotlight | Wilmington News
A controversial panel backed by Health Secretary Robert F. Kennedy Jr. voted 8-6 to ease access to BPC-157, a popular but unproven peptide, despite FDA scientists raising red flags over lack of evidence. The panel, packed with industry-connected doctors and pharmacists, including David Pope of Xifin Pharmacy Solutions who argued for patient autonomy, cleared the way for specialty pharmacies to make their own versions. Six more peptides are up for similar votes — but with the FDA’s track record of ignoring outside advice, the real outcome remains uncertain. Listen in comfort:Get a discount on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.